Wolverine Trading, LLC Innoviva, Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $168,379 - $236,187	-16,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$11.49 - $15.26 $187,287 - $248,738	16,300 New	16,300 $231,000
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $211,050 - $305,550	-21,000 Closed	0 $0
Q2 2019 Aug 20, 2019	BUY	$13.1 - $14.95 $22,270 - $25,415	1,700 Added 8.81%	21,000 $306,000
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $264,217 - $387,158	19,300 New	19,300 $271,000
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $240,112 - $314,072	-17,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $10,904 - $12,560	800 Added 4.88%	17,200 $262,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $11,040 - $13,591	800 Added 5.13%	16,400 $273,000
Q3 2017 Nov 15, 2017	BUY	$12.06 - $14.12 $188,136 - $220,272	15,600	15,600 $220,000

240

77M

53.9K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.26B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.